Leonie S. Young
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Leonie S. Young has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Damir Varešlija
Royal College of Surgeons in Ireland
47 shared publications Fiona T. Bane
28 shared publications- Manuel Valiente
Spanish National Cancer Research Centre Madrid Spain
25 shared publications - Mihaela Ola
Royal College of Surgeons in Ireland Dublin Ireland
25 shared publications Eva Ortega-Paino
24 shared publications- Marie McIlroy
Department of Surgery, RCSI University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland
24 shared publications
Latest Publications
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Survival analysis of the 37-gene signature derived from CD74+ microglia/macrophages across TCGA primary tumors cohorts
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Survival analysis of the 37-gene signature derived from CD74+ microglia/macrophages across TCGA primary tumors cohorts
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 13 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Ibudilast reduces PD-L1 expression in CD74+ from patient-derived organotypic cultures
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 13 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Ibudilast reduces PD-L1 expression in CD74+ from patient-derived organotypic cultures
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 14 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Patient-derived organotypic cultures (PDOC) treated with Ibudilast
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 14 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Patient-derived organotypic cultures (PDOC) treated with Ibudilast
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Ibudilast reduces brain metastasis in vivo without comprising the viability of cancer cells in vitro
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Ibudilast reduces brain metastasis in vivo without comprising the viability of cancer cells in vitro
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 11 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Ibudilast reverts the protumorigenic signature of CD74+ microglia/macrophages in vivo
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 11 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Ibudilast reverts the protumorigenic signature of CD74+ microglia/macrophages in vivo
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 9 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Gene set enrichment analysis of CD74+ microglia/macrophages
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 9 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Gene set enrichment analysis of CD74+ microglia/macrophages
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 10 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
List of marker genes defining each CD45⁺ immune cell population identified by single-cell RNA-seq
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 10 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
List of marker genes defining each CD45⁺ immune cell population identified by single-cell RNA-seq
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
List of flow cytometry antibodies
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
List of flow cytometry antibodies
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
CD74+ cells are mainly BMDM with transcriptional enrichment in OXPHOS pathway
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
CD74+ cells are mainly BMDM with transcriptional enrichment in OXPHOS pathway
- Open Access
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 18 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Upregulated pathways in the CD74+ myeloid clusters vs CD74- myeloid clusters
- 2 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 18 from MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders
Upregulated pathways in the CD74+ myeloid clusters vs CD74- myeloid clusters